News

September 5, 2013 — Scientists at Rice University have trapped bismuth in a nanotube cage to tag stem cells for X-ray tracking. Details of the work by a team from Rice and collaborators at the University of Houston, St. Luke's Episcopal Hospital and the Texas Heart Institute appear in the Journal of Materials Chemistry B.

Home September 05, 2013
Home
Feature

Researchers announced this week that an attempt to expand cardiac resynchronization therapy (CRT) to include more patients with heart failure has failed and an international clinical trial ended early to prevent potential harm to patients.

Home September 05, 2013
Home
News

September 5, 2013 — ITC Nexus Holding Co., a company in hemostasis management and point-of-care (POC) testing, announced it has acquired Accumetrics, a specialist in assessing patient response to all major antiplatelet therapies. Terms of the transaction were not disclosed.

Home September 05, 2013
Home
News

HeartWare International Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to commence enrollment in an additional patient cohort for ENDURANCE, the company's pivotal, destination therapy clinical study.

Home September 05, 2013
Home
Technology

Terumo has introduced the GlideSheath Slender Hydrophilic Introducer Sheath, a 6 French sheath that has the outer diameter of a 5 French sheath. Its narrower profile makes it optimal for radial access, especially in women with smaller radial access.

Home September 04, 2013
Home
News

C. R. Bard Inc. has entered into a definitive merger agreement to acquire Rochester Medical Corp. at a price of $20 per share, or approximately $262 million in the aggregate. The Rochester Medical board of directors unanimously approved the agreement and will recommend that the company's shareholders approve the transaction.

Home September 04, 2013
Home
News

Based on its recent analysis of the cardiology informatics market, Frost & Sullivan recognizes Ascend HiT with the 2013 North America Frost & Sullivan Award for Customer Value Leadership. With the introduction of CardioAnalytics, Ascend has proved that it is at the vanguard of the cardiology market's efforts to enhance quality and analytics. This product complements and extends the best-of-breed Ascend CV reporting products, and in the process, positions the company to deliver one of the most crucial elements of the cardiology value chain—cardiovascular procedural reporting.

Home September 04, 2013
Home
X0000_SJM_EnligHTN next gen illustration
Feature

September 3, 2013 — St. Jude Medical Inc. announced the CE mark approval of its next-generation EnligHTN renal denervation system for treating patients with drug-resistant, uncontrolled hypertension. The EnligHTN system was display during the 2013 European Society of Cardiology (ESC) meeting Aug. 31 to Sept. 3.

Home September 03, 2013
Home
News

St. Jude Medical Inc. today announced U.S. Food and Drug Administration (FDA) approval and first use of MediGuide Enable Ablation Catheters. The ablation catheters, which are used to treat specific irregular heartbeats, expand the MediGuide platform for St. Jude Medical.

Home September 03, 2013
Home
News

Avinger Inc. has received CE Mark approval for Pantheris – a system that combines directional atherectomy capabilities with real-time intravascular visualization to remove plaque from blocked arteries. Pantheris is designed to remove the blockage while avoiding the disruption of normal arterial wall structures. This new type of image-guided atherectomy is referred to as lumectomy. Currently, approximately 200 million patients worldwide suffer from peripheral artery disease (PAD).

Home September 03, 2013
Home
News

A listing of remote image viewing systems being shown at RSNA 2013

Home September 01, 2013
Home
Technology

Ascendian Healthcare Consulting has announced a comprehensive vendor neutral archive (VNA) acceleration solution that enables healthcare organizations rapid accessibility, efficiency and shared utilization of medical imaging assets.

Home August 30, 2013
Home
Technology

August 30, 2013 — PFM Medical received U.S. Food and Drug Administration (FDA) premarket approval (PMA) for its Nit-Occlud Patent Ductus Arteriosus (PDA) device, a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus.

Home August 30, 2013
Home
Technology

Philips Healthcare launched the Epiq ultrasound system, a first-of-its-kind ultrasound architecture that offers a new approach to creating ultrasound images. Making its debut at the European Society of Cardiology (ESC) 2013 Congress in Amsterdam, Epiq features a new imaging technology called nSIGHT that, when combined with Philips' new Anatomical Intelligence technology, delivers faster speed and improved image clarity. It has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Home August 30, 2013
Home
Diagnosing Pericardial Disease Using Multi-modality Imaging Protocols
Feature

To counter the significant levels of morbidity and mortality associated with pericardial disease (disease of the sac around the heart), experts from the American Society of Echocardiography (ASE), the Society for Cardiovascular Magnetic Resonance (SCMR), and the Society of Cardiovascular Computed Tomography (SCCT) came together to review evidence and provide future guidance to clinicians. For the first time, an expert consensus statement on the appropriate use of multimodality imaging in the diagnosis and management of pericardial diseases will be published in the September issue of the Journal of the American Society of Echocardiography (JASE). The writing group was chaired by Allan L. Klein, M.D., FASE, director of Cardiovascular Imaging Research and the Pericardial Center and an echocardiographer from the esteemed Cleveland Clinic in Cleveland, Ohio.

Home August 30, 2013
Home
Subscribe Now